Key result
Elevated levels of immature platelet fraction and reticulated platelets were associated with acute and chronic phases of ischemic stroke and TIA across 6 included studies.
Why the study?
To evaluate the potential role of IPF and RPs in cerebrovascular events, specifically ischemic and hemorrhagic stroke and TIAs, and assess their clinical utility in stroke monitoring and management.
Are elevated levels of immature platelet fraction and reticulated platelets associated with stroke severity, recurrence, and etiology in patients with cerebrovascular events?
Systematic Review
Are elevated levels of immature platelet fraction and reticulated platelets associated with stroke severity, recurrence, and etiology in patients with cerebrovascular events?
Immature platelet fraction and reticulated platelets are emerging biomarkers that may aid in risk stratification and predicting outcomes in patients with acute ischemic stroke and TIA.
No takes yet. Share an insight, caveat, or question.
IPF/RPs may aid acute stroke risk stratification; leaves open standardization and prospective validation before routine use.
Tsankof et al. (2025) conducted a systematic review in Cerebrovascular events (ischemic stroke, hemorrhagic stroke, TIA). Immature platelet fraction (IPF) and reticulated platelets (RPs) was evaluated on Stroke severity, recurrence, and underlying etiology. Elevated levels of immature platelet fraction and reticulated platelets were associated with acute and chronic phases of ischemic stroke and TIA across 6 included studies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: